TRPV4 as a therapeutic target for joint diseases

Area of Science:

• Biomedical Engineering
• Skeletal Biology
• Rheumatology

Background:

• Biomechanical forces significantly influence joint tissue health and disease, particularly osteoarthritis.
• Cellular mechanosensation pathways are critical for understanding and potentially treating joint pathologies.
• Osteoarthritis pathogenesis involves complex interactions between mechanical stress and cellular responses.

Purpose of the Study:

• To investigate the role of Transient Receptor Potential Vanilloid 4 (TRPV4) channels in joint physiology and pathology.
• To explore TRPV4 as a potential therapeutic target for disease-modifying osteoarthritis drugs (DMOADs).
• To understand how TRPV4 mediates cellular responses to mechanical and osmotic stimuli in musculoskeletal tissues.

Main Methods:

• Analysis of TRPV4 function as a mechanosensor in cartilage, bone, and synovium.
• Examination of skeletal phenotypes in patients with TRPV4 mutations and in Trpv4 knockout mouse models.
• Assessment of TRPV4's role in engineered cartilage regeneration and response to chemical activation.

Main Results:

• TRPV4 mutations are linked to skeletal dysplasias and arthropathies.
• Trpv4 genetic knockout leads to osteoarthritis development and reduced osteoclast function.
• Chemical activation of TRPV4 in engineered cartilage mimics anabolic effects of mechanical loading, promoting tissue growth.

Conclusions:

• TRPV4 is a crucial sensor of mechanical, pain, and inflammatory signals in joint tissues.
• Dysregulation of TRPV4 activity contributes to joint pathologies like osteoarthritis.
• Targeting TRPV4 presents a viable therapeutic avenue for managing joint diseases and promoting tissue regeneration.